MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202647075351 A) filed by Shanghai Argo Biopharmaceutical Co. , Ltd. on June 18, 2026, for Compositions And Methods For Inhibiting Expression Of Sodium Voltage-Gated Channel Alpha Subunit 9 (scn9a).
Inventors include Shu, Dongxu; Shao, Pengcheng Patrick; and Xia, Shiwei.
The application for the patent was published on June 26, 2026, under issue no. 26/2026.
Abstract: Compositions and methods useful to reduce expression of sodium voltage-gated channel alpha subunit 9 (SCN9A) gene and for treatment of SCN9A-associated diseases and conditions are provided. Provided are SCN9A dsRNA agents, SCN9A antisense polynucleotide agents, compositions comprising SCN9A dsRNA agents, and compositions comprising SCN9A antisense polynucleotide agents that can be used to reduce SCN9A expression in cells and subjects.
Disclaimer: Curated by HT Syndication.
